Treating People with Parkinson's Disease: A New Pocket Guide to Help Make a Complex Disease Easier to Navigate

Wednesday, August 25, 2021

7:00-8:00 PM ET


The creators of AMDA's new pocket guide, "Parkinson's Disease and Psychosis in the Post-Acute and Long-Term Care Setting," will introduce and discuss key elements of this new resource, designed to help physicians and advanced care practitioners better recognize features of Parkinson's disease and Parkinson's disease psychosis. Speakers will discuss appropriate and effective interventions and how to work with staff to gather the information needed to manage and monitor this complex disease. Participants will have an opportunity to ask questions during the live webinar or can submit questions ahead of time to Linda Lang at

 Learning Objectives

By the end of the webinar, participants should be able to:

  • Express confidence in the diagnosis of Parkinson’s disease and discriminating it from parkinsonism and from other causes, including Parkinson’s Plus disorders.
  • List the interventions appropriate to the appearance of various adverse drug reactions (ADRs) from Parkinson’s disease treatment.
  • Recognize non-motor features and their impact on quality of life.
  • Describe the interval history required to monitor a PALTC resident with Parkinson’s disease at the time of statutory visits.
  • Differentiate Parkinson’s disease psychosis from other causes of behavioral problems/psychosis and choose appropriate treatment.

 Speakers: Alexander Baumgartner, MD; Nora Reznickova, MD; David Smith, MD, CMD; Lauren Seeberger, MD 

Credit Information:

  • 1.0 CME
  • 1.0 CMD Clinical
  • 1.0 MOC

Credit Statements:

AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This live activity has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1.0 Clinical hours toward certification or recertification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM. Each physician should claim only those hours of credit actually spent on the activity.

Maintenance of Certification (MOC): 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points and patient safety credit in the American Board of Internal Medicine’s (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Information: 

The Society requires the disclosure of all speaker/faculty/planner’s relevant financial relationships; presence of off-label use of a device or medication; and discussion of any experimental, new, or evolving topic prior to each accredited education activity.

If the learner perceives any bias toward a commercial product or service, advocation of unscientific approaches to diagnosis or therapy, or recommendation, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients please report this to the Society’s staff.

All relationships have been identified, mitigated, and resolved. 

The following AMDA Online Education Committee members have financial relationships to report: Robert Zorowitz, MD, MBA, CMD – United Health Group: Stock Shareholder; all others have no relationships to disclose.

AMDA staff have no financial relationships to disclose.